SCHEMBL3721847

SCHEMBL3721847

CCC(c1ccccc1)C1C(N(Cc2ccccc2)Cc2ccccc2)N(C(=O)O)CCC1n1c(=O)n(Cc2ccccc2)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 4/20 0.40
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ OPRL1 P41146 4/20 0.35
▸ OPRM1 P35372 3/20 0.35
▸ CACNA1G O43497 1/20 0.34
▸ CACNA1H O95180 1/20 0.34
▸ AGTR2 P50052 2/20 0.33
▸ OPRK1 P41145 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3811730 0.86 SIGMAR1 (0.36) OPRL1OPRM1CACNA1GCACNA1HOPRK1
SCHEMBL4681519 0.85 CHRM5 (0.38) AGTR2GAAKMT2AKDM4EALDH1A1
SCHEMBL4674627 0.83 OPRM1 (0.41) CYP2D6OPRL1OPRM1OPRK1KDM4E
SCHEMBL3721849 0.79 CACNA1G (0.42) C5AR1CYP3A4CYP2D6CACNA1GCACNA1H
SCHEMBL1832947 0.69 CACNA1G (0.38) CYP3A4OPRM1CACNA1GCACNA1HMEN1
SCHEMBL3811734 0.69 SIGMAR1 (0.41) OPRM1CACNA1GCACNA1HOPRK1
SCHEMBL1835303 0.66 OPRM1 (0.41) CYP2D6OPRL1OPRM1OPRK1KDM4E
SCHEMBL4683069 0.65 CYP2D6 (0.66) C5AR1CYP3A4CYP2D6CACNA1GCACNA1H
SCHEMBL4681520 0.64 CHRM5 (0.38) CACNA1GCACNA1HMEN1GAAKMT2A
SCHEMBL3799851 0.62 OPRL1 (0.42) C5AR1CYP3A4CYP2D6OPRL1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
EP-1997805-A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans Commissariat à l'Energie Atomique (FR) 2008-12-03 — — EP disclosed
Send feedback